🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in India / NCT07304596
Recruiting Not applicable

Responsiveness of Hindi Version of Oral Health Impact Profile for Periodontitis (OHIP-P-HIN)

NCT07304596 · tracked via the Priya Life Science India tracker
Sponsor
Postgraduate Institute of Dental Sciences Rohtak
Phase
Not applicable
Started
2025-11-12
Last updated
2026-05-26

Condition(s) studied

PeriodontitisOral Health Quality of Life (OHQoL) Was Assessed

Investigational drug(s) / intervention(s)

Non Surgical Periodontal Therapy

Non Surgical Periodontal Therapy: Full mouth subgingival instrumentation will be done

Study summary

The distribution- and anchor-based methods will be used to estimate the Minimal Important Difference (MID) of the OHIP-P-HIN. Two established distribution-based approaches, the standardized effect size (ES) and standardized response mean (SRM) will be calculated. The ES is calculated by dividing the mean change scores in the OHIP-P-HIN from baseline by the standard deviation of the baseline scores. And the SRM are computed as ratios of the mean change score divided by its standard deviation. The anchor-based approach will be applied by using the global transition scale as the anchor.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * ≥18 years of age * patients able to understand and complete questionnaires independently * confirmed diagnosis of periodontitis Exclusion Criteria: * Patients with systemic diseases such as acquired immunodeficiency syndrome or diabetes mellitus * pregnancy * required prophylactic antibiotic coverage prior to dental treatment, * patients with bleeding disorders * patients who had received non-surgical periodontal therapy within the preceding eight weeks.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
PGIDS Rohtak Rohtak Haryana Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07304596 on ClinicalTrials.gov ↗ ← All trials in India